Info
Insider Trading

Insider Transactions Reported by 11 Insiders of Agomab Therapeutics NV

Symbol: AGMB on Nasdaq
Location: Antwerpen

There are no Buy or Sell transactions made by insiders since 19 Mar 2025

Agomab Therapeutics NV executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Philippe Constantin Wiesel	Chief Medical Officer				18 Mar 2026
Ellen Lefever	General Counsel				18 Mar 2026
Andrea Saez Borderias	Chief Development Officer				18 Mar 2026
Isabel Verduyn van Weegen	Director				18 Mar 2026
Paul Henryk van der Horst	Chief Business Officer				18 Mar 2026
Angelika Martha Jahreis	Director				18 Mar 2026
Pierre Thadee Victor Kemula	Chief Financial Officer				18 Mar 2026
Ohad Hammer	Director				18 Mar 2026
Colin Michael Bond	Director				18 Mar 2026
Tim Jasper Knotnerus	Chief Executive Officer, Director				18 Mar 2026
David R. Epstein	Director				18 Mar 2026

Recent Insider Transactions by Companies or Individuals for Agomab Therapeutics NV

Showing up to 300 most recent insider transactions from the last 12 months.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership
Tim Jasper Knotnerus	AGMB	Common shares					0	34,394	18 Mar 2026	By TJK Life Sciences B.V.
Tim Jasper Knotnerus	AGMB	Common shares					0	10,823	18 Mar 2026	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.